The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity - Wikidata - wikimedia - TriplyDB

The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity

The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity

http://www.wikidata.org/entity/Q28215615

about

sameAs

Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression Catalytic activity of human ADAM33 Proteolytic Origin of the Soluble Human IL-6R In Vivo and a Decisive Role of N-Glycosylation A biosensor for the activity of the "sheddase" TACE (ADAM17) reveals novel and cell type-specific mechanisms of TACE activation Discovery of novel human transcript variants by analysis of intronic single-block EST with polyadenylation site.Age-related changes in the proteoglycans of human skin. Specific cleavage of decorin to yield a major catabolic fragment in adult skin.Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10 Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes.MMP-9 cleaves SP-D and abrogates its innate immune functions in vitro Embelin inhibits TNF-α converting enzyme and cancer cell metastasis: molecular dynamics and experimental evidence.ADAM17 mediates MMP9 expression in lung epithelial cells.Protein kinase C-alpha mediates TNF release process in RBL-2H3 mast cells.Metalloproteinases: their role in arthritis and potential as therapeutic targets.Using fluorogenic peptide substrates to assay matrix metalloproteinases.ADAM33: a novel therapeutic target for asthma.Activation of matrix metalloproteinases following anti-Aβ immunotherapy; implications for microhemorrhage occurrence.Structure-based rational design of peptide hydroxamic acid inhibitors to target tumor necrosis factor-α converting enzyme as potential therapeutics for hepatitis.Is there a future for TNF promoter polymorphisms?Matrix metalloproteinase-dependent microsomal prostaglandin E synthase-1 expression in macrophages: role of TNF-α and the EP4 prostanoid receptor.Spinal matrix metalloproteinase 3 mediates inflammatory hyperalgesia via a tumor necrosis factor-dependent mechanism.RAGE and TGF-β1 Cross-Talk Regulate Extracellular Matrix Turnover and Cytokine Synthesis in AGEs Exposed Fibroblast Cells Molecular mechanism for activation and regulation of matrix metalloproteinases during bacterial infections and respiratory inflammation.Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases.Protective role of matrix metalloproteinase-9 in ozone-induced airway inflammation.Patients with chronic three-vessel disease in a 15-year follow-up study: genetic and non-genetic predictors of survival.ADAM proteases, ErbB pathways and cancer.Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology.Mmp23b promotes liver development and hepatocyte proliferation through the tumor necrosis factor pathway in zebrafish.Matrix metalloproteinases as modulators of inflammation.Alveolar macrophage inflammatory mediator expression is elevated in the setting of alcohol use disorders.Alcohol abuse and smoking alter inflammatory mediator production by pulmonary and systemic immune cells.Matrix metalloproteinase (MMP)-1 and MMP-3 induce macrophage MMP-9: evidence for the role of TNF-alpha and cyclooxygenase-2.Prointerleukin-18 is activated by meprin beta in vitro and in vivo in intestinal inflammation.ADAM function in embryogenesis A TLR2 agonist in German cockroach frass activates MMP-9 release and is protective against allergic inflammation in mice.Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock.Persistent p55TNFR expression impairs T cell responses during chronic tuberculosis and promotes reactivation Intercellular adhesion molecule 1: recent findings and new concepts involved in mammalian spermatogenesis Increased ectodomain shedding of lung epithelial cell adhesion molecule 1 as a cause of increased alveolar cell apoptosis in emphysema.Proteolytic processing of the prion protein in health and disease.

P2860

Q24568374-0F818445-F34C-454A-B117-51B2D9867804 Q28191609-D73FB876-0E2D-40B4-880F-A23C363DBDC5 Q28468416-D46346F1-588B-48E5-84B9-6A7F3BC7E09A Q28831250-E160D757-84D4-4705-905B-3BD670F746D7 Q30882126-4F20443E-C96E-4651-B8DB-912154D90601 Q31134336-44D97603-850C-4335-9F15-865FE666338F Q33498106-DC5B3FA1-C6F3-45D8-9A1B-4AB7FFC58AED Q33559001-92223FA7-3D64-4DF1-B269-6091B801EEE9 Q34364261-2691C620-E2AB-4813-8D18-B5D2BBBC9836 Q34410435-2CD54AD1-70DF-4DF3-90DE-A000F79324CD Q34558156-1D08B737-168A-41D2-ABD3-194649868839 Q35048928-69E9ABA9-F516-4360-B791-F0BA767B72A5 Q35056019-187CF4F4-F410-4404-97D7-84498C92A8B5 Q35162671-E9644AD0-777D-46FE-A66A-F6A9D4D22445 Q35186652-F532442C-B75A-451B-A7C3-F141F2BFA866 Q35240865-94002B41-1E21-4387-961A-0B67898C8B8C Q35659760-E882A6BC-DE00-4B17-81CB-978654765841 Q35671253-8D03D333-2E12-4843-8FCC-C8258ADDF186 Q35740060-55D4AFF6-CB6F-4C19-BDF7-4B732C0D07EE Q35940473-91F5BCBD-155A-44A2-B97F-6AC6EE38D714 Q35970395-F5C97783-D986-480C-9A04-043CD3234415 Q35970398-AA05BBF2-387C-44C1-B669-F3D1AA7299CB Q36113481-E368A594-E629-4366-BC54-946E87DE7254 Q36130794-7D5C18B7-C552-456A-AFF5-0E96834611B1 Q36153982-EFEB52FD-E34E-41F3-A939-D2AEEA9C1C7E Q36187030-47665135-B144-422B-ACA4-05556E4DAADF Q36195064-9AB463F1-32A5-43DB-991E-D16B055D20FF Q36278360-39C35EBD-8D70-47C5-A0EA-48FAE1AF49BC Q36449536-C00CCFC6-191F-40FD-A1E3-822026841822 Q36578646-443E5894-52B7-442F-9BBE-D85699F8BC5D Q36698703-DD67309A-42B9-4784-839B-8E7BF90D3814 Q36753433-03D1819F-9754-4AD0-AF77-5FF0D66F9A83 Q36968427-55CDC51B-DDB4-422A-A583-D8A3C5B86293 Q37303309-101BD4DA-9C66-4486-9F7C-5D206EF4F840 Q37359009-DFB2E978-C974-4D44-A88C-F3832D650CA1 Q37444400-51D4C8C9-CF0B-447B-9B1C-981F66C7A7EE Q37518463-D3A08DD5-D351-4396-8FF9-A6ED84F04B57 Q37578039-920D2E46-15E0-4070-90AB-8EFDB13E9252 Q37600213-0EC69901-451D-40AC-BEAD-EDFCBF79BCA7 Q38079239-1D66627B-C046-47FF-BAB7-1AAE1CBAA38B

P2860

The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity

http://www.wikidata.org/entity/Q28215615

description

2002 nî lūn-bûn

@nan

2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

The tumor necrosis factor-alph ...... defined substrate selectivity

@ast

The tumor necrosis factor-alph ...... defined substrate selectivity

@en

The tumor necrosis factor-alph ...... defined substrate selectivity

@nl

type

label

The tumor necrosis factor-alph ...... defined substrate selectivity

@ast

The tumor necrosis factor-alph ...... defined substrate selectivity

@en

The tumor necrosis factor-alph ...... defined substrate selectivity

@nl

prefLabel

The tumor necrosis factor-alph ...... defined substrate selectivity

@ast

The tumor necrosis factor-alph ...... defined substrate selectivity

@en

The tumor necrosis factor-alph ...... defined substrate selectivity

@nl

P1433

Q28215615-27F00BA9-5481-4C8A-BE6C-EA366BC599A8

P1476

Q28215615-FE2F841C-05FE-42D4-AA8F-341852ACF252

P2093

Q28215615-232C1042-7FC7-45B5-908A-702C6DFC0184

Q28215615-25212475-DB45-4E3D-A803-E5B9220A1112

Q28215615-6AB51B07-63A1-4CB2-9C91-E4DE5F6C1D0F

Q28215615-7C7BAB87-654F-4B27-9C04-6AB311BBCD04

Q28215615-7DE6580E-4093-455A-B7D4-A34D6508A7F7

Q28215615-95D4F3B2-E22B-4DEC-AB85-AD02FDA89D04

Q28215615-A9988C62-6135-4EEF-A8BC-CAAB7AA9AC5B

Q28215615-A9C9CF6A-3E99-4132-99F0-239BC4A94B8A

Q28215615-ADFEE1B2-0B84-435A-B9B1-F4158A78F22D

Q28215615-C1AFA7D6-44C2-4BAF-9B2D-62E663570201

P304

Q28215615-60D0AC09-7DB8-4F59-9822-E6F604763F8C

P31

Q28215615-CEC2131D-2196-4EE4-81EA-688708ADA2F2

P3181

Q28215615-CDB1C09C-B179-4174-9903-DABC38C54C76

P356

Q28215615-5B4DBD90-7FBF-4B6D-8BE4-9B25F632D965

P407

Q28215615-5956DC3E-C548-4A2B-A55F-1B55A9EF3254

P433

Q28215615-3B18DBD2-C7E7-4DDA-A231-2DDA8D9ED859

P478

Q28215615-322A4B67-D7C4-49D9-B53B-26D07A4427CC

P577

Q28215615-BAAC5667-27B1-44A2-B850-F3F77CA25601

P698

Q28215615-B2D65580-3D72-4450-82BC-871CB6B9CE02

P3181

P356

P1433

P1476

The tumor necrosis factor-alph ...... defined substrate selectivity

@en

P2093

Anne Howe

http://www.w3.org/2001/XMLSchema#string

Gregory M Waitt

http://www.w3.org/2001/XMLSchema#string

Inder Patel

http://www.w3.org/2001/XMLSchema#string

J David Becherer

http://www.w3.org/2001/XMLSchema#string

Justin Mitchell

http://www.w3.org/2001/XMLSchema#string

Kevin Blackburn

http://www.w3.org/2001/XMLSchema#string

Marcia L Moss

http://www.w3.org/2001/XMLSchema#string

Marcos E Milla

http://www.w3.org/2001/XMLSchema#string

Mary Moyer

http://www.w3.org/2001/XMLSchema#string

Mohita J Mohan

http://www.w3.org/2001/XMLSchema#string

P304

9462-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

5055343

http://www.w3.org/2001/XMLSchema#string

P356

10.1021/BI0260132

http://www.w3.org/2001/XMLSchema#string

P407

P433

30

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2002-07-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12135369

http://www.w3.org/2001/XMLSchema#string